{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T05:16:24Z","timestamp":1768972584172,"version":"3.49.0"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2016,9,29]],"date-time":"2016-09-29T00:00:00Z","timestamp":1475107200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0163444","type":"journal-article","created":{"date-parts":[[2016,9,29]],"date-time":"2016-09-29T18:52:38Z","timestamp":1475175158000},"page":"e0163444","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":34,"title":["Multi-Center Evaluation of the Fully Automated PCR-Based Idylla\u2122 KRAS Mutation Assay for Rapid KRAS Mutation Status Determination on Formalin-Fixed Paraffin-Embedded Tissue of Human Colorectal Cancer"],"prefix":"10.1371","volume":"11","author":[{"given":"J\u00e9r\u00f4me","family":"Solassol","sequence":"first","affiliation":[]},{"given":"Julie","family":"Vendrell","sequence":"additional","affiliation":[]},{"given":"Bruno","family":"M\u00e4rkl","sequence":"additional","affiliation":[]},{"given":"Christian","family":"Haas","sequence":"additional","affiliation":[]},{"given":"Beatriz","family":"Bellosillo","sequence":"additional","affiliation":[]},{"given":"Clara","family":"Montagut","sequence":"additional","affiliation":[]},{"given":"Matthew","family":"Smith","sequence":"additional","affiliation":[]},{"given":"Brendan","family":"O\u2019Sullivan","sequence":"additional","affiliation":[]},{"given":"Nicky","family":"D\u2019Haene","sequence":"additional","affiliation":[]},{"given":"Marie","family":"Le Mercier","sequence":"additional","affiliation":[]},{"given":"Morten","family":"Grauslund","sequence":"additional","affiliation":[]},{"given":"Linea Cecilie","family":"Melchior","sequence":"additional","affiliation":[]},{"given":"Emma","family":"Burt","sequence":"additional","affiliation":[]},{"given":"Finbarr","family":"Cotter","sequence":"additional","affiliation":[]},{"given":"Daniel","family":"Stieber","sequence":"additional","affiliation":[]},{"given":"Fernando de Lander","family":"Schmitt","sequence":"additional","affiliation":[]},{"given":"Valentina","family":"Motta","sequence":"additional","affiliation":[]},{"given":"Calogero","family":"Lauricella","sequence":"additional","affiliation":[]},{"given":"Richard","family":"Colling","sequence":"additional","affiliation":[]},{"given":"Elizabeth","family":"Soilleux","sequence":"additional","affiliation":[]},{"given":"Matteo","family":"Fassan","sequence":"additional","affiliation":[]},{"given":"Claudia","family":"Mescoli","sequence":"additional","affiliation":[]},{"given":"Christine","family":"Collin","sequence":"additional","affiliation":[]},{"given":"Jean-Christophe","family":"Pag\u00e8s","sequence":"additional","affiliation":[]},{"given":"Peter","family":"Sillekens","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2016,9,29]]},"reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrc1097","article-title":"RAS oncogenes: the first 30 years","volume":"3","author":"M Malumbres","year":"2003","journal-title":"Nat Rev Cancer"},{"issue":"14","key":"ref2","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.4155\/fmc.11.121","article-title":"Inhibition of Ras for cancer treatment: the search continues","volume":"3","author":"AT Baines","year":"2011","journal-title":"Future Med Chem"},{"issue":"8","key":"ref3","doi-asserted-by":"crossref","first-page":"16365","DOI":"10.3390\/ijms140816365","article-title":"Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention","volume":"14","author":"D Colussi","year":"2013","journal-title":"Int J Mol Sci"},{"issue":"4","key":"ref4","first-page":"269","article-title":"Molecular phenotypes of colorectal cancer and potential clinical applications","volume":"3","author":"JM Kocarnik","year":"2015","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"15065","DOI":"10.1038\/nrdp.2015.65","article-title":"Colorectal cancer","volume":"1","author":"EJ Kuipers","year":"2015","journal-title":"Nat Rev Dis Primers"},{"issue":"13","key":"ref6","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.ejca.2015.05.017","article-title":"Prevalence of RAS mutations and individual variation patterns among patients with metastatic colorectal cancer: A pooled analysis of randomised controlled trials","volume":"51","author":"M Peeters","year":"2015","journal-title":"Eur J Cancer"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012","volume":"49","author":"J Ferlay","year":"2013","journal-title":"Eur J Cancer"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"RL Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 3","key":"ref9","doi-asserted-by":"crossref","first-page":"iii1","DOI":"10.1093\/annonc\/mdu260","article-title":"Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"25","author":"E Van Cutsem","year":"2014","journal-title":"Ann Oncol"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/1756283X13498660","article-title":"Panitumumab in the management of patients with KRAS wild-type metastatic colorectal cancer","volume":"7","author":"CM Hocking","year":"2014","journal-title":"Therap Adv Gastroenterol"},{"issue":"10","key":"ref11","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1200\/JCO.2007.14.7116","article-title":"Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer","volume":"26","author":"RG Amado","year":"2008","journal-title":"J Clin Oncol"},{"issue":"17","key":"ref12","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1056\/NEJMoa0804385","article-title":"K-ras mutations and benefit from cetuximab in advanced colorectal cancer","volume":"359","author":"CS Karapetis","year":"2008","journal-title":"N Engl J Med"},{"issue":"11","key":"ref13","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJMoa1305275","article-title":"Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer","volume":"369","author":"JY Douillard","year":"2013","journal-title":"N Engl J Med"},{"issue":"8","key":"ref14","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.ctrv.2015.05.008","article-title":"Extended RAS analysis for anti-epidermal growth factor therapy in patients with metastatic colorectal cancer","volume":"41","author":"JR Hecht","year":"2015","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/annonc\/mdu378","article-title":"Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials","volume":"26","author":"MJ Sorich","year":"2015","journal-title":"Ann Oncol"},{"key":"ref16","unstructured":"NCCN clinical practice guidelines in oncology: colon cancer v.3.2015. National Comprehensive Cancer Network. Available: http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/colon.pdf<\/ext-link>; 2015."},{"issue":"62","key":"ref17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta18620","article-title":"KRAS mutation testing of tumours in adults with metastatic colorectal cancer: a systematic review and cost-effectiveness analysis","volume":"18","author":"M Westwood","year":"2014","journal-title":"Health Technol Assess"},{"issue":"3","key":"ref18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11523-011-0181-x","article-title":"Uptake of KRAS mutation testing in patients with metastatic colorectal cancer in Europe, Latin America and Asia","volume":"6","author":"F Ciardiello","year":"2011","journal-title":"Target Oncol"},{"issue":"5","key":"ref19","first-page":"183","article-title":"RAS-testing in colorectal cancer: Belgian guidelines","volume":"9","author":"A Jouret-Mourin","year":"2015","journal-title":"Belg J Med Oncol"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.yexmp.2015.09.004","article-title":"Multi-center evaluation of the novel fully-automated PCR-based Idylla\u2122<\/sup> BRAF Mutation Test on formalin-fixed paraffin-embedded tissue of malignant melanoma","volume":"99","author":"L Melchior","year":"2015","journal-title":"Exp Mol Pathol"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jmoldx.2015.12.005","article-title":"Multicenter Evaluation of a Novel, Automated Rapid Detection System of BRAF Status in Formalin-Fixed, Paraffin-Embedded Tissues","volume":"18","author":"AI Schiefer","year":"2016","journal-title":"J Mol Diagn"},{"issue":"9","key":"ref22","doi-asserted-by":"crossref","first-page":"e0138245","DOI":"10.1371\/journal.pone.0138245","article-title":"Clinical Validation of Targeted Next Generation Sequencing for Colon and Lung Cancers","volume":"10","author":"N D'Haene","year":"2015","journal-title":"PLoS One"},{"key":"ref23","unstructured":"Association for Molecular Pathology. ASCP\/CAP\/AMP\/ASCO Evaluation of Molecular Markers for Colorectal Cancer Draft Recommendations. Available: http:\/\/www.amp.org\/committees\/clinical_practice\/CRCOpenComment.cfm<\/ext-link>; 2015. Refers to Guideline on the Evaluation of Molecular Markers for Colorectal Cancer Expert Panel Draft Recommendations Summary for Open Comment Period."},{"issue":"6","key":"ref24","doi-asserted-by":"crossref","first-page":"768","DOI":"10.4161\/cbt.28550","article-title":"Characterization of rare transforming KRAS mutations in sporadic colorectal cancer","volume":"15","author":"JH Tong","year":"2014","journal-title":"Cancer Biol Ther"},{"issue":"11","key":"ref25","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nrd4389","article-title":"Drugging the undruggable RAS: Mission possible?","volume":"13","author":"AD Cox","year":"2014","journal-title":"Nat Rev Drug Discov"},{"issue":"9\u201310","key":"ref26","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.cancergen.2013.09.004","article-title":"Low frequency KRAS mutations in colorectal cancer patients and the presence of multiple mutations in oncogenic drivers in non-small cell lung cancer patients","volume":"206","author":"L Jiang","year":"2013","journal-title":"Cancer Genet"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0163444","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T10:55:56Z","timestamp":1540032956000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0163444"}},"subtitle":[],"editor":[{"given":"John","family":"Souglakos","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2016,9,29]]},"references-count":26,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,9,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0163444","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,29]]}}}